NCT02098707

Brief Summary

Pharmacotherapy with dopaminergic medications and deep brain stimulation cannot provide significant improvements in postural instability in Parkinson's disease, whereas previous reports of physical interventions have suggested promising results. The investigators want to study the effects of the multidisciplinary intensive rehabilitation treatment (MIRT) on balance disorders in Parkinson Disease (PD).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 21, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 28, 2014

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

March 28, 2014

Status Verified

March 1, 2014

Enrollment Period

1 year

First QC Date

March 21, 2014

Last Update Submit

March 24, 2014

Conditions

Keywords

Stabilometric PlatformRehabilitationBalance DisordersFalls

Outcome Measures

Primary Outcomes (1)

  • Standard deviation (SD) of trunk sway

    With respect to the average centre of gravity the standard deviation (SD) of trunk sway will be calculated: total, in antero-posterior \[AP\] and in medio-lateral \[ML\] direction. We will also calculate a statokinesigram, that is the layout of a line connecting the successive positions of the center of pressure during the recording, and the area of the ellipse containing 90% of the sampled positions of the center of pressure. These measurements will be calculated with open eyes (OE), and while the patient was performing a cognitive task (counting, \[OEC\]). All physical measurements will be obtained during the ON phase of levodopa medication and at the same time of the day to reduce the influence of medication fluctuations. Statistical analysis with Wilcoxon signed rank test for non parametric data will be performed to analyze differences between T0 and T1 values of all variables. Results will be considered statistically significant for p \< 0.05.

    up to 4 weeks

Secondary Outcomes (1)

  • BBS scale

    up to 4 weeks

Study Arms (1)

30 Parkinson disease patients

30 patients (12 M, 18 F, mean age 66,8 ± 8,7) diagnosed with PD in stage 3 of Hoen\&Yahr (mean Unified Parkinson Disease Rating Scale \[UPDRS\] III 18.8±10.5) will undergo a balance training using a stabilometric platform.

Other: Stabilometric Platform

Interventions

Stabilometric platform is a device used for assessment and training of balance basing on ground reaction force evaluation in static conditions.

30 Parkinson disease patients

Eligibility Criteria

Age58 Years - 74 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

30 patients (12 M, 18 F, mean age 66,8 ± 8,7) diagnosed with PD in stage 3 of Hoen\&Yahr (mean UPDRS III 18.8±10.5) according to the UK Brain Bank criteria.

You may qualify if:

  • patients diagnosed with PD in stage 3 of Hoen \& Yahr according to the United Kingdom Brain Bank criteria.

You may not qualify if:

  • Atypical parkinsonisms, patients with osteoarticular and muscular pathologies, PD patients with Mini Mental State Examination \< 26, patients with other disorders of balance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ospedale Generale di Zona "Moriggia-Pelascini"

Gravedona, Como, 22015, Italy

RECRUITING

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Giuseppe Frazzitta, MD

    Ospedale Generale di Zona "Moriggia-Pelascini", Gravedona ed Uniti (CO), Italy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2014

First Posted

March 28, 2014

Study Start

June 1, 2013

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

March 28, 2014

Record last verified: 2014-03

Locations